Download 2016
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Crime, Law Enforcement, and Punishment
Shirley Papers 48 Research Materials, Crime Series Inventory Box Folder Folder Title Research Materials Crime, Law Enforcement, and Punishment Capital Punishment 152 1 Newspaper clippings, 1951-1988 2 Newspaper clippings, 1891-1938 3 Newspaper clippings, 1990-1993 4 Newspaper clippings, 1994 5 Newspaper clippings, 1995 6 Newspaper clippings, 1996 7 Newspaper clippings, 1997 153 1 Newspaper clippings, 1998 2 Newspaper clippings, 1999 3 Newspaper clippings, 2000 4 Newspaper clippings, 2001-2002 Crime Cases Arizona 154 1 Cochise County 2 Coconino County 3 Gila County 4 Graham County 5-7 Maricopa County 8 Mohave County 9 Navajo County 10 Pima County 11 Pinal County 12 Santa Cruz County 13 Yavapai County 14 Yuma County Arkansas 155 1 Arkansas County 2 Ashley County 3 Baxter County 4 Benton County 5 Boone County 6 Calhoun County 7 Carroll County 8 Clark County 9 Clay County 10 Cleveland County 11 Columbia County 12 Conway County 13 Craighead County 14 Crawford County 15 Crittendon County 16 Cross County 17 Dallas County 18 Faulkner County 19 Franklin County Shirley Papers 49 Research Materials, Crime Series Inventory Box Folder Folder Title 20 Fulton County 21 Garland County 22 Grant County 23 Greene County 24 Hot Springs County 25 Howard County 26 Independence County 27 Izard County 28 Jackson County 29 Jefferson County 30 Johnson County 31 Lafayette County 32 Lincoln County 33 Little River County 34 Logan County 35 Lonoke County 36 Madison County 37 Marion County 156 1 Miller County 2 Mississippi County 3 Monroe County 4 Montgomery County -
Reducing HIV Infection in Young Women in Southern Africa
SPOTLIGHT ON PREVENTION Reducing HIV Infection in Young Women in Southern Africa: The Key to Altering Epidemic Trajectories in a Generalized, Hyperendemic Setting Quarraisha Abdool Karim, PhD, and Hilton Humphries, MA The global HIV pandemic has evolved into Communities in Southern Africa1 are burdened a complex mosaic of epidemics within and with the highest HIV prevalence in the world. One between countries, with no single solution for segment of the general population is especially vul- preventing HIV infection. Increasing access to nerable: girls and young women. Some public health antiretroviral treatment has reduced AIDS-related experts now believe that the way to alter epidemic mortality and morbidity rates, but—with nearly trajectories in this region is to use rigorous inter- three million new infections each year—we are los- vention science to create innovative, comprehen- ing the HIV prevention battle (Joint United Nations sive prevention programming that targets girls and Programme on HIV/AIDS [UNAIDS] 2008), primar- young women. ily in sub-Saharan Africa. HIV Infection in Southern Africa For prevention efforts to succeed, prevention pro- Southern Africa is at the epicenter of the global gramming must be tailored to the specific charac- pandemic. Home to less than 1 percent of the teristics of the epidemic that is unfolding in the area global population, it carries a disproportionate to be targeted. Assessing an epidemic at the local or 17 percent of the global burden of HIV infection. regional level is an important first step to enhancing UNAIDS describes the region’s epidemic typology and customizing prevention responses. This requires as a generalized, hyperendemic epidemic charac- a nuanced understanding of who is at highest risk of terized by uniquely high HIV prevalence, ongoing infection and what drives that risk. -
JEREMY E. WULFF Department of Chemistry, University of Victoria
CURRICULUM VITAE (Abbreviated) JEREMY E. WULFF Department of Chemistry, University of Victoria 1. EDUCATION and TRAINING a. Degrees Held degree institution year obtained PhD University of Calgary 2004 BSc (Hons., Co-op) University of Victoria 1999 b. Postdoctoral Experience NSERC Postdoctoral fellow, Harvard University 2005-2007 2. SELECTED POSITIONS HELD PRIOR to APPOINTMENT at UVic period company, job title, duties 1999 : 01-06 Methylgene, research assistant, synthetic organic methodology 1998 : 05-08 Dept. of National Defense, analytical chemist, ICP-MS analysis 1997 : 05-08 Merck Frosst Canada, research assistant, natural product total synthesis 3. ACADEMIC APPOINTMENTS period rank academic unit 07/2007-06/2013 Assistant Professor (renewed 2009) UVic Chemistry 07/2013- Associate Professor with Tenure UVic Chemistry 4. SIGNIFICANT ADMINISTRATIVE or LEADERSHIP ROLES period role 2013- Director, Chemistry for the Medical Sciences BSc Program 2015- Director, CAMTEC Facility for Biomolecular Sample Preparation 5. HONOURS and AWARDS 5a. Recent Awards (since Appointment at UVic): 2012-2022: Canada Research Chair (Tier II) in Bioactive Small Molecule Synthesis [Renewed in 2017] 2011-2019: Michael Smith Foundation for Health Research Career Scholar Award [Renewed in 2016] 2014: Thieme Chemistry Journal Award Top-20-Under-40 on Vancouver Island [Only academic awarded since the re-launch of the program] 2015: Selected for a Synform Young Career Focus Article th [7 researcher worldwide selected for summary] 5b. Earlier Fellowships and Awards: NSERC PDF, John Kendall Thesis Award, I.W. Killam Memorial Scholarship, AHFMR Studentship, NSERC PGSA and PGS-B, Don Tavares Teaching Excellence Award. page 1 of 9 CURRICULUM VITAE (Abbreviated) 6. MAJOR FIELD(S) of SCHOLARLY or PROFESSIONAL INTEREST Organic synthesis, medicinal chemistry, chemical biology, synthetic polymers 7. -
Nelson R Mandela School of Medicine, University of Natal, Private Bag X7, Congella 4013, Durban
Doris Duke Medical Research Institute (2nd Floor), University of KwaZulu-Natal, 719 Umbilo Road / (Private Bag X7) Congella, 4013, Durban, South Africa Tel: +27-31-260 4555 Fax: +27-31-260 4549 E-mail: [email protected] MEDIA STATEMENT ISSUED BY: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) STRICTLY EMBARGOED UNTIL TUESDAY, 24 FEBRUARY 2015, 12h15 (US SEATTLE) and 22h15 (SOUTH AFRICA) New tenofovir gel study shows no effect on HIV prevention: Lower than expected gel use impact FACTS trial results 24 February 2015 – HIV prevention for women suffered a setback today when a study conducted by the Follow-on African Consortium for Tenofovir Studies (FACTS) reported that its results do not confirm the HIV protective effect of tenofovir gel shown previously in the CAPRISA 004 trial. The FACTS 001 trial involving 2059 South African women showed no overall HIV prevention benefit of the gel. However, a sub-group analysis based on gel use confirmed by tenofovir detection in genital fluid, showed a 52% reduction in HIV infection. The CAPRISA study had reported in 2010 that tenofovir, applied as a gel before and after sex, reduced HIV infection by 39% overall and by 54% in women who used the gel consistently. CAPRISA is an official research institute of the The results of the FACTS 001 study, which was led by Professors Helen Rees and University of KwaZulu- Natal and Columbia Glenda Gray, were markedly influenced by the large proportion of women who did University. not apply the gel consistently. This is similar to the experiences in the VOICE CAPRISA was (Vaginal and Oral Interventions to Control the Epidemic) trial involving women from established in 2002 through a CIPRA grant Uganda, South Africa and Zimbabwe. -
What Can We Learn from the HIV Response About Pandemic Preparedness for SARS-Cov-2 and Beyond
What can we learn from the HIV response about pandemic preparedness for SARS-CoV-2 and beyond CLASS SESSIONS Dates: June 7 and 8, 2021 Time : 8:30am to 12:30pm Location: TBD/Zoom INSTRUCTORS Salim S Abdool Karim [email protected] / [email protected] Quarraisha Abdool Karim qa4@cumc. columbia.edu / [email protected] Course Description The SARS-CoV-2 pandemic is the most recent and challenging pandemic facing humanity in the 21st century. Country responses to this 2020 pandemic provide important insights on retuns on public health investments made in response to the HIV pandemic but also shaped by political leadership and the balance or prioritisation of saving lives, livelihoods and viral suppression. The role of science and knowledge generation has been unprecedented including the development of several efficacious vaccines. The emergence of new variants of concern of SARS-CoV-2 even as SARS-CoV-2 vaccines are being rolled out across the globe; continued high rates of infections and deaths underscore our inter-dependence and the many research questions that remain unanswered. Global responses to the HIV pandemic have important lessons for responses to SARS-CoV-2. This interactive course will share lessons learnt from responses to SARS-CoV-2 including its interaction with HIV and what lessons our HIV response has for responding to SARS-CoV-2. Course Objectives By the end of the course, students will have a greater appreciation of key elements of an effective response to SARS-CoV-2; the interaction between SARS-CoV-2 and HIV; and lessons from HIV for SARS-CoV-2. -
2021 Gruber Genetics Prize Recognizes Hematologist- Oncologist and Geneticist Stuart H
Media Contact: A. Sarah Hreha +1 (203) 432‐6231 [email protected] Online Newsroom: https://gruber.yale.edu/news‐media Hematologist-Oncologist Stuart Orkin Receives $500,000 Gruber Genetics Prize for His Groundbreaking Research on the Genetics of Inherited Blood Disorders Stuart H. Orkin March 2, 2021, New Haven, CT – The 2021 Gruber Genetics Prize recognizes hematologist‐ oncologist and geneticist Stuart H. Orkin, M.D., for his pioneering discoveries of the genetic underpinnings of blood disorders. His remarkable body of work has not only revolutionized our understanding of how these illnesses occur but has also led to promising new gene‐based therapies for thalassemia and sickle cell disease, two inherited blood disorders that affect millions of people around the world. Dr. Orkin is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School and the Dana‐Farber/Boston Children’s Cancer and Blood Disorders Center, and an Investigator of the Howard Hughes Medical Institute. The prize, which includes a $500,000 award, will be presented to Orkin at the annual meeting of the American Society of Human Genetics in October. “Dr. Orkin has led the field of hematology for more than 40 years,” says Eric Olson, professor at UT Southwestern and member of the Selection Advisory Board. “His work has been deeply mechanistic, groundbreaking and impactful. Through a series of seminal discoveries, he has helped to unravel key molecular mysteries behind how blood cells develop—and how inherited blood disorders occur.” Early in his career, Orkin identified many genetic mutations behind the various types of thalassemia, an inherited blood disorder characterized by inadequate production of the protein beta‐globin, one of two chains of hemoglobin, the oxygen‐carrying component of red cells. -
Brief Bio Quarraisha Abdool Karim, Phd Quarraisha Abdool Karim, Phd
Brief Bio Quarraisha Abdool Karim, PhD Quarraisha Abdool Karim, PhD, is an infectious diseases epidemiologist, who’s main research focuses are on understanding the evolving HIV epidemic in South Africa; factors influencing acquisition of HIV infection in adolescent girls; and sustainable strategies to introduce ART in resource-constrained settings. She is the Associate Scientific Director of CAPRISA, Professor of Epidemiology at the Mailman School of Public Health, Columbia University and Adjunct Professor in Public Health at the Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa. Her most important scientific contribution to HIV prevention is the CAPRISA 004 tenofovir gel trial which demonstrated effectiveness of coitally-applied tenofovir gel in preventing HIV and HSV-2 acquisition in women. She is the Principal Investigator of the CAPRISA 008 tenofovir gel implementation effectiveness trial. Further, her research on HIV epidemiology in young women has been widely utilized in developing responses to the HIV epidemic in southern Africa. She was part of the team, initially as its leader, that conducted the SAPiT trial on TB-HIV treatment, which has shaped international treatment guidelines on the clinical management of co-infected patients. In terms of policy and implementation, she currently chairs the SANAC Prevention Technical Task Team, which draws upon her past experience in establishing South Africa’s National AIDS and STD Programme in 1995. She is the Vice President for the African Academy of Science, Southern Africa, and Foreign Associate Member of the Institute of Medicine (IoM) of the National Academies. She has been the recipient of several international and national awards for her scientific contributions, including the Order of Mapungubwe, bronze, for outstanding work in the field of HIV/AIDS and TB research, and health policy development. -
Engagement of AAS Fellows and Affiliates in 2019
Engagement of AAS Fellows and Affiliates in 2019 We give special thanks to Fellows and Affiliates who have advanced the work of the Academy by being involved in the delivery of these African Academy of Sciences activities: The AAS Scientific Working Groups The AAS has 18 Scientific Working Groups (SWGs) that are made up of Fellows of the AAS who serve as Chars and members of these groups. The groups advice on global and regional trends within their disciplines/thematic areas, lead discussions and/or advise the AAS on topical issues affecting or that could affect the continent, write policy briefs, assist the AAS to come up with strategies for the application of emerging technologies among other roles. African Synchotron Initiative Malik Maaza Paco Sereme South Africa Burkina Faso Chair Physical Sciences Agricultural and Nutritional Shabaan Khalil Sciences Egypt Agriculture Physical Sciences Mary Abukutsa-Onyango Chair Kenya Mohamed Mostafa El-Fouly Agricultural and Nutritional Members Egypt Sciences Paul-Kingsley Buah-Bassuah Agricultural and Nutritional Sciences Ghana Bassirou Bonfoh Physical Sciences Members Togo Kadambot Siddique Agricultural and Nutritional Australia Sossina Haile Sciences Ethiopia & United States of America Agricultural and Nutritional Sciences Engineering Technology and Applied Thameur Chaibi Mohamed Sciences Oluyede Ajayi Tunisia Nigeria Geological, Environmental, Earth Agricultural and Nutritional Sciences Simon Connell and Space Sciences South Africa Anthony Youdeowei Akiça Bahri Physical Sciences Nigeria Tunisia -
Federation Member Society Nobel Laureates
FEDERATION MEMBER SOCIETY NOBEL LAUREATES For achievements in Chemistry, Physiology/Medicine, and PHysics. Award Winners announced annually in October. Awards presented on December 10th, the anniversary of Nobel’s death. (-H represents Honorary member, -R represents Retired member) # YEAR AWARD NAME AND SOCIETY DOB DECEASED 1 1904 PM Ivan Petrovich Pavlov (APS-H) 09/14/1849 02/27/1936 for work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged. 2 1912 PM Alexis Carrel (APS/ASIP) 06/28/1873 01/05/1944 for work on vascular suture and the transplantation of blood vessels and organs 3 1919 PM Jules Bordet (AAI-H) 06/13/1870 04/06/1961 for discoveries relating to immunity 4 1920 PM August Krogh (APS-H) 11/15/1874 09/13/1949 (Schack August Steenberger Krogh) for discovery of the capillary motor regulating mechanism 5 1922 PM A. V. Hill (APS-H) 09/26/1886 06/03/1977 Sir Archibald Vivial Hill for discovery relating to the production of heat in the muscle 6 1922 PM Otto Meyerhof (ASBMB) 04/12/1884 10/07/1951 (Otto Fritz Meyerhof) for discovery of the fixed relationship between the consumption of oxygen and the metabolism of lactic acid in the muscle 7 1923 PM Frederick Grant Banting (ASPET) 11/14/1891 02/21/1941 for the discovery of insulin 8 1923 PM John J.R. Macleod (APS) 09/08/1876 03/16/1935 (John James Richard Macleod) for the discovery of insulin 9 1926 C Theodor Svedberg (ASBMB-H) 08/30/1884 02/26/1971 for work on disperse systems 10 1930 PM Karl Landsteiner (ASIP/AAI) 06/14/1868 06/26/1943 for discovery of human blood groups 11 1931 PM Otto Heinrich Warburg (ASBMB-H) 10/08/1883 08/03/1970 for discovery of the nature and mode of action of the respiratory enzyme 12 1932 PM Lord Edgar D. -
Angewandte Chemie International Edition: 1993 02/15/20 1
Baran Group Meeting Kelly J. Eberle Angewandte Chemie International Edition: 1993 02/15/20 1 January 1993: A Timeline Hot topics: 1993: In Chemistry -Fullerenes Martin Luther King Jr. Day February -Porphyrins observed in all 50 states NH N -!-lactam antibiotics -Electron Transfer Reactions World Trade Center bombing in N HN New York City (1992 Nobel Prize Winner, Rudolph Marcus of Caltech) March Nobel Prize in Chemistry 1993: Baby born April DNA-Based Chemistry in NJ -Kary Mullis (PCR) ‘Walker, Texas -Michael Smith (oligonucleotide-based, site-directed Ranger’ TV debut mutagenesis) May ACIEE ’93 Top Authors: Volume 32 Dietmar Stalke (9) Budweiser commercial dog June Spuds Mackenzie dies 12 Issues Waldemar Adam (6) 654 articles Roland Boese (6) Steven Spielberg’s Jurrasic Park Arnold Rheingold (6) premieres in theaters Paul Schleyer (6) July Most cited articles (not including reviews) Pfaltz et al, 566 (630) Golfer Jack Nicklaus wins the US Chiral Phosphinoaryldihydrooxazoles as Ligands in Asymmetric Senior Open by one stroke August Catalysis: Pd‐Catalyzed Allylic Substitution Ruth Bader Ginsburg sworn in Meijer et al, 1308 (488) as US Supreme Court Justice Poly(propylene imine) Dendrimers: Large‐Scale Synthesis by September Hetereogeneously Catalyzed Hydrogenations Lehn et al, 69 (315) ‘Seinfeld’ wins Emmy for October Multicomponent Self‐Assembly: Spontaneous Formation of a Cylindrical Outstanding Comedy Series Complex from Five Ligands and Six Metal Ions Nelson Mandela and F. W. deKlerk Lehn et al, 703 (301) awarded Nobel Peace Prize Self‐Assembly, Structure, and Spontaneous Resolution of a Trinuclear November Triple Helix from an Oligobipyridine Ligand and NiII Ions Herrmann et al, 1157 (266) Snoop Dogg releases December debut album ‘Doggystyle’ Methyltrioxorhenium(VII) as Catalyst for Epoxidations: Structure of the Active Species and Mechanism of Catalysis NASA STS-61 mission launches Endeavour to repair Hubble Telescope 4 TSRI papers: Boger, Ghadiri, Sharpless, Nicolaou (review, The Battle of Calicheamicin ") Baran Group Meeting Kelly J. -
News Release
NEWS RELEASE Legacy of BC’s First Nobel Laureate Lives On Celebrating the 25th anniversary of Michael Smith’s Nobel Prize Vancouver, BC — This October, organizations from across British Columbia’s scientific research community are celebrating the powerful legacy of Dr. Michael Smith, the province’s first Nobel Laureate, as we mark the 25th anniversary of his Nobel Prize. Smith’s impact and foundational work in genomics inspired many and helped propel our province to international prominence as a world leader in genomics research. Smith’s Nobel Prize was awarded for his work on site-directed mutagenesis, a revolutionary technique that allows scientists to make a genetic mutation precisely at any spot in a DNA molecule, helping us understand more about how genes work, and what happens when they go wrong. This technique has led to new tests and treatments for diseases such as cancer, with made-in-BC treatments and practices putting the province near the top of world rankings for cancer outcomes. It has also contributed to better understanding of conditions such as Alzheimer’s, cystic fibrosis and immunodeficiency disorders like HIV/AIDS. A man of humble origins, Smith donated his entire Nobel Prize award. Half of the $500,000 prize went to researchers working in schizophrenia research, at the time a notoriously under-funded area. The other half he gave to Science World British Columbia and to the Society for Canadian Women in Science and Technology, enabling the group to continue supporting and promoting women in their education and career choices. The Nobel Prize, and Smith’s dedication to using his position to advance BC research as a whole, was a game changer for the province, vaulting the expertise of local scientists onto the world stage and putting BC on the map as a place for world-class research. -
Quarraisha Abdool Karim Wins Twas-Lenovo Prize
QUARRAISHA ABDOOL KARIM WINS TWAS-LENOVO PRIZE South African scientist named winner of TWAS's most prestigious award for commitment to life-saving research that protects African women from HIV/AIDS MUSCAT, Sultanate of Oman – South African epidemiologist Quarraisha Abdool Karim was named winner of the 2014 TWAS-Lenovo Science Prize Sunday for her life-saving research into medical and social strategies against HIV and AIDS. The award, one of the most prestigious honours given to scientists from the developing world, was announced here in a special ceremony during the yearly General Meeting of The World Academy of Sciences (TWAS). Abdool Karim's work focuses on a topical anti-HIV gel that appears to dramatically reduce HIV infection, while giving women direct, effective control over their health. The annual prize includes an award of USD100,000 provided by Lenovo, the global leader in consumer, commercial, and enterprise technology that is the largest PC company in the world. "We have a great admiration and respect for the work of Dr. Abdool Karim," said TWAS President Bai Chunli. "She has an exemplary record of high-impact science, and there is a deep humanity to her work. Just as important, she has helped to train hundreds of young African scientists who are expanding the research into HIV and tuberculosis. She really is a model scientist, and a tremendous inspiration to colleagues across the world." "Innovation is how Lenovo achieves competitive differentiation and drives new market opportunities. Lenovo's global scale and emphasis on innovation give us a degree of visibility regarding the health and well-being of the communities and markets we serve," said Yuanqing Yang, Chairman & CEO of Lenovo.